NASDAQ
MabCure, Inc. (MBCI) has a price/fcf ratio of -71.19x as of Wednesday, May 27, 2026. This represents a 58.53% increase compared to its 12-month average of -171.67x. The price-to-free-cash-flow ratio measures a stock's price relative to its free cash flow per share, reflecting how efficiently a company generates cash.
No price data available for this timeframe.